| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/01/2000 | US6096302 Detection of nervous degradation with aging |
| 08/01/2000 | US6096275 For testing urine, blood, saliva or other body fluids for ph, oxidation-reduction potential or electrical resistance to assess the internal biological environment of an individual. |
| 08/01/2000 | US6096272 Automated microbiological testing apparatus and methods therefor |
| 08/01/2000 | US6096271 With support to retain slide in horizontal positiion, aspirator connected to vacuum source, activator to bring aspirator into contact with fluid only, controller to move aspirator to selected position, automatic |
| 08/01/2000 | US6096269 For rapid analysis of biological fluids |
| 08/01/2000 | US6096268 Chromogenic and turbidimetric assay device |
| 08/01/2000 | US6096267 System for detecting base contaminants in air |
| 08/01/2000 | US6096186 Method for determining exhaustion of an electrochemical gas sensor |
| 08/01/2000 | US6096172 Bonding dna probe molecules using light; medical diagnosis |
| 08/01/2000 | US6095982 Spectroscopic method and apparatus for optically detecting abnormal mammalian epithelial tissue |
| 08/01/2000 | US6095974 Disposable fiber optic probe |
| 08/01/2000 | US6095681 Method for operating a sensor to differentiate between analytes in a sample |
| 08/01/2000 | US6095000 Method and apparatus for treating samples |
| 08/01/2000 | US6094999 Rotatable batch sampler with wedge-shaped cone |
| 08/01/2000 | CA2207454C Fired cartridge examination method and imaging apparatus |
| 08/01/2000 | CA2182365C Centrifuge tube and adaptor |
| 08/01/2000 | CA2175061C Muteins of beta-galactosidase fragments having increased activity |
| 08/01/2000 | CA2175060C Oxidation-resistant muteins of beta-galactosidase fragments |
| 08/01/2000 | CA2080262C Multi-stage storage case for cassettes or cassette blocks |
| 08/01/2000 | CA2047717C Monoclonal antibodies for small moieties, methods therefor |
| 08/01/2000 | CA2006322C Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides |
| 08/01/2000 | CA1341066C Small peptides which inhibit binding to t-4 receptors and act as immunogens |
| 08/01/2000 | CA1341065C Detection of a unique chlamydia strain associated with acute respiratory disease |
| 07/29/2000 | CA2297137A1 New gene with down-regulated expression in metastatic human melanoma cells and a protein coded thereby, methods of production, and use thereof |
| 07/29/2000 | CA2296969A1 Quantitative determination of analytes in a heterogeneous system |
| 07/27/2000 | WO2000043939A1 Describing and storing method of alignment information |
| 07/27/2000 | WO2000043812A1 Focused formation fluid sampling probe |
| 07/27/2000 | WO2000043794A1 Measurement of accelerated whole blood clotting time |
| 07/27/2000 | WO2000043793A1 A FACS METHOD FOR DETECTION OF GPIIb/IIIa INHIBITOR DEPENDENT ACTIVATORS IN PLASMA SAMPLES |
| 07/27/2000 | WO2000043792A2 Methods and kits for sequencing polypeptides |
| 07/27/2000 | WO2000043791A2 Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases |
| 07/27/2000 | WO2000043790A2 Compositions and methods for the diagnosis and treatment of tumor |
| 07/27/2000 | WO2000043789A1 Method and diagnostic kit for diagnosis of endometriosis |
| 07/27/2000 | WO2000043788A1 Method for assaying creatine kinase isozyme activity and assay reagent |
| 07/27/2000 | WO2000043787A1 Electrophoretic assays to assess conformational changes of integrins induced by ligand binding |
| 07/27/2000 | WO2000043786A1 Testing device and method chromatographic |
| 07/27/2000 | WO2000043785A1 Improvements in or relating to displacement assays |
| 07/27/2000 | WO2000043784A1 Simple method for labeled conjugate production |
| 07/27/2000 | WO2000043783A2 Assays involving colloids and non-colloidal structures |
| 07/27/2000 | WO2000043782A2 Removal of prions from blood, plasma and other liquids |
| 07/27/2000 | WO2000043781A2 Growth differentiation factor inhibitors and uses therefor |
| 07/27/2000 | WO2000043780A1 Methods for detecting changes to cellular components |
| 07/27/2000 | WO2000043779A1 Method for identifying the ligands of a receptor capable of being internalized |
| 07/27/2000 | WO2000043778A1 Indicator device |
| 07/27/2000 | WO2000043777A1 Devices and methods for the detection and identification of crystals in biological fluids |
| 07/27/2000 | WO2000043776A1 Process for pan-genomic determination of macromolecular atomic structures |
| 07/27/2000 | WO2000043774A2 Detection of small molecules by use of a piezoelectric sensor |
| 07/27/2000 | WO2000043773A1 Method for determining oil quality and oil quality sensor |
| 07/27/2000 | WO2000043772A1 Micro-machined thin film hydrogen gas sensor, and method of making and using the same |
| 07/27/2000 | WO2000043762A1 Method and device for detecting the formation of a material deposit on a heat flow sensor |
| 07/27/2000 | WO2000043756A1 Blood methemoglobin analysis |
| 07/27/2000 | WO2000043754A1 Raman optrode processes and devices for detection of chemicals and microorganisms |
| 07/27/2000 | WO2000043747A1 Method and device for proof testing valves |
| 07/27/2000 | WO2000043744A1 Method and apparatus for measuring viscous heating of viscoelastic materials |
| 07/27/2000 | WO2000043553A1 Identifying, monitoring, and treating women for breast precancer or cancer |
| 07/27/2000 | WO2000043552A2 Multifunctional and multispectral biosensor devices and methods of use |
| 07/27/2000 | WO2000043551A1 Determining viral load in double negative t cells |
| 07/27/2000 | WO2000043550A2 Method and apparatus for measuring factors in mammary fluids |
| 07/27/2000 | WO2000043548A1 Therapeutic and diagnostic applications of prostatic acid phosphatase in prostate cancer |
| 07/27/2000 | WO2000043540A1 A method of dna sequencing |
| 07/27/2000 | WO2000043539A2 Immobilization of molecules on surfaces via polymer brushes |
| 07/27/2000 | WO2000043536A1 Glucose sensing using metal-ligand complexes |
| 07/27/2000 | WO2000043535A2 Composition and device for detecting leukocytes in urine |
| 07/27/2000 | WO2000043534A1 Method and apparatus for the automated generation of nucleic acid ligands |
| 07/27/2000 | WO2000043526A1 Mammalian serine racemase |
| 07/27/2000 | WO2000043522A1 Gene causative of rothmund-thomson syndrome and gene product |
| 07/27/2000 | WO2000043521A2 Endogenetic nucleic fragment associated with an autoimmune disease, marking method and reagent |
| 07/27/2000 | WO2000043519A2 Neisseria meningitidis polypeptides |
| 07/27/2000 | WO2000043518A1 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 07/27/2000 | WO2000043517A1 Basb055 polynucleotide and polypeptide from neisseria meningitidis. uses thereof |
| 07/27/2000 | WO2000043515A2 Methods of monitoring hiv drug resistance |
| 07/27/2000 | WO2000043511A1 Polypeptide |
| 07/27/2000 | WO2000043509A2 Polynucleotides and their applications in diagnostics |
| 07/27/2000 | WO2000043506A1 Novel nucleic acid and amino acid sequences |
| 07/27/2000 | WO2000043498A2 Human liver progenitors |
| 07/27/2000 | WO2000043495A2 33 human secreted proteins |
| 07/27/2000 | WO2000043492A2 Method of site specific labeling of proteins and uses therefor |
| 07/27/2000 | WO2000043420A1 Reagents and methods useful for detecting diseases of the breast |
| 07/27/2000 | WO2000043419A2 Exocytosis pathway proteins and methods of use |
| 07/27/2000 | WO2000043414A1 Tripeptide compounds useful as selective inhibitors of aminopeptidase a and corresponding pharmaceutical compositions |
| 07/27/2000 | WO2000043410A2 Novel odorant receptors in drosophila |
| 07/27/2000 | WO2000043199A1 Magnetically responsive gel particle |
| 07/27/2000 | WO2000043038A1 Methods and devices for delivery of agents to breast milk ducts |
| 07/27/2000 | WO2000042912A1 Polarized light scattering spectroscopy of tissue |
| 07/27/2000 | WO2000042909A1 Method for diagnosing the presence and extent of halitosis activity |
| 07/27/2000 | WO2000042841A1 Methods for identifying, treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer |
| 07/27/2000 | WO2000028318A3 Apparatus and methods relating to humidified air and to olfactory monitoring |
| 07/27/2000 | WO2000027832A3 Thiazole derivatives as ppar gamma ligands |
| 07/27/2000 | WO2000025814A3 Component for vaccine against serogroup b meningococci |
| 07/27/2000 | WO2000023618B1 Polymorphism in a tgf-beta gene correlated to osteoporosis |
| 07/27/2000 | WO2000023588A3 G-protein coupled receptors |
| 07/27/2000 | WO2000021550A3 Methods and compositions for treating neurodegenerative diseases |
| 07/27/2000 | WO2000011171A3 Human rna-associated proteins |
| 07/27/2000 | WO2000007038A9 Protein fragment complementation assays |
| 07/27/2000 | WO2000005253A9 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2) |
| 07/27/2000 | WO2000004157A3 Cloning and characterisation of novel mammalian peptidases |
| 07/27/2000 | WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors |
| 07/27/2000 | WO1999064867A8 Multiple assay method |
| 07/27/2000 | WO1999064033A9 Phosphodiesterase-v modulator drugs and their uses |
| 07/27/2000 | WO1999063994A9 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE |